Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
21.06. | City View Green Holdings Inc: City View closes financing tranche, hires Rocket Invest | 1 | Stockwatch | ||
21.06. | City View Green Holdings Inc.: City View Green Announces First Tranche Closing and Extension of its Non-Brokered Private Placement | 481 | Newsfile | Toronto, Ontario--(Newsfile Corp. - June 20, 2024) - City View Green Holdings Inc. (CSE: CVGR) (OTC Pink: CVGRF) ("City View" or the "Company"), an innovative Canadian-based cannabis-infused edibles... ► Artikel lesen | |
06.05. | City View Green Holdings Inc: City View Green extends $1-million financing | 1 | Stockwatch | ||
06.05. | City View extends private placement of up to $1M | 1 | Seeking Alpha | ||
06.05. | City View Green Holdings Inc.: City View Extends Private Placement of up to $1,000,000 | 458 | Newsfile | Toronto, Ontario--(Newsfile Corp. - May 6, 2024) - City View Green Holdings Inc. (CSE: CVGR) (OTC Pink: CVGRF) (the "Company" or "City View"), an innovative Canadian-based cannabis-infused edibles... ► Artikel lesen | |
17.04. | City View Green Holdings Inc: City View Green exits retail cannabis via Budd Hutt | 1 | Stockwatch | ||
17.04. | City View Green Holdings Inc. Exits Retail Cannabis Through Ownership in Budd Hutt & Announces Director Resignation | 392 | Newsfile | Toronto, Ontario--(Newsfile Corp. - April 17, 2024) - City View Green Holdings Inc. (CSE: CVGR) (OTCQB: CVGRF) ("City View" or the "Company"), an innovative Canadian-based cannabis-infused edibles... ► Artikel lesen | |
15.03. | City View: Entain needs DNA change to meet 2024 recovery | 18 | SBC News | ||
04.03. | City View Green Holdings Inc: City View Green arranges $1-million private placement | 1 | Stockwatch | ||
04.03. | City View Green Holdings Inc.: City View Announces Private Placement of Up To $1,000,000 | 511 | Newsfile | Toronto, Ontario--(Newsfile Corp. - March 4, 2024) - City View Green Holdings Inc. (CSE: CVGR) (OTC Pink: CVGRF) (the "Company" or "City View"), an innovative Canadian-based cannabis-infused edibles... ► Artikel lesen | |
07.11.23 | City View Green Holdings Inc. Announces Strategic Review | 327 | Newsfile | Toronto, Ontario--(Newsfile Corp. - November 7, 2023) - City View Green Holdings Inc. (CSE: CVGR) (OTC Pink: CVGRF) ("City View" or the "Company"), an innovative Canadian-based cannabis-infused edibles... ► Artikel lesen | |
24.08.23 | City View Green Holdings Inc. Executes Amendment to Revolving Line of Credit and Issues Bonus Warrants | 287 | Newsfile | Toronto, Ontario--(Newsfile Corp. - August 25, 2023) - City View Green Holdings Inc. (CSE: CVGR) (OTC Pink: CVGRF) ("City View" or the "Company"), an innovative Canadian-based cannabis-infused edibles... ► Artikel lesen | |
11.08.23 | Rob Fia: Early Warning Report Issued Pursuant to National Instrument 62-103 in Respect of the Acquisition of Shares of City View Green Holdings Inc. | 719 | Newsfile | Toronto, Ontario--(Newsfile Corp. - August 11, 2023) - In accordance with regulatory requirements, Rob Fia reports that on August 4, 2023, he acquired 4,898,230 common shares of City View Green Holdings... ► Artikel lesen | |
31.07.23 | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 31.07.2023 | 593 | Xetra Newsboard | The following instruments on XETRA do have their first trading 31.07.2023 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 31.07.2023
Aktien
1 CA2935701078 Ensign Energy Services... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
BAYER | 27,465 | -0,24 % | Bayer-Aktie an DAX-Spitze: Charttechnisch spannend | Mit einem Plus von gut drei Prozent rangiert das Papier von Bayer zu Wochenbeginn an der Spitze im DAX. Neuigkeiten von Unternehmens- oder Analystenseite, die die recht deutlichen Kursaufschläge begründen... ► Artikel lesen | |
PFIZER | 28,375 | +0,11 % | Pfizer Aktie: Prognosen für Q2 2024 | Die Pfizer-Aktie steht vor einer herausfordernden Periode, da Analysten für das zweite Quartal 2024 einen Gewinnrückgang bei steigendem Umsatz erwarten. Prognosen deuten auf einen Quartalsgewinn von... ► Artikel lesen | |
SANOFI | 96,39 | +0,19 % | Sanofi SA-Aktie: Kurs klettert leicht (93,32 €) | An der Börse liegt die Sanofi SA-Aktie derzeit im Plus. Der jüngste Kurs betrug 93,32 Euro. Am Aktienmarkt hat sich heute die Sanofi SA-Aktie zwischenzeitlich um 0,45 Prozent verteuert. Der Kurs des... ► Artikel lesen | |
INNOCAN PHARMA | 0,171 | +1,79 % | InnoCan Pharma: Countdown für die FDA-Zulassung! | ||
DERMAPHARM | 35,250 | 0,00 % | Dividendenbekanntmachungen (28.06.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACADIA REALTY TRUST US0042391096 0,18 USD 0,1681 EUR ACADIAN TIMBER CORP CA0042721005 0,29 CAD 0,1977 EUR AG MORTGAGE INVESTMENT... ► Artikel lesen | |
BEVCANNA ENTERPRISES | 0,433 | -5,25 % | Bevcanna Enterprises Inc (3): Bevcanna to acquire Greenflame Distribution for $2.5M | ||
DIGICANN VENTURES | 0,005 | 0,00 % | Digicann Ventures Inc.: Digicann Ventures Announces Agreement to Extend Maturity Date for Convertible Debentures | ||
BAUSCH HEALTH | 5,533 | +0,20 % | Bausch Health Companies Inc.: Bausch Health Responds to Market Rumors | LAVAL, QC / ACCESSWIRE / July 24, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company") has become aware of a news article issued by Reorg® today, citing unnamed sources.The article... ► Artikel lesen | |
WPD PHARMACEUTICALS | 0,002 | +100,00 % | WPD Pharmaceuticals Inc: WPD to settle debt with shares | ||
SINOPHARM | 2,168 | -1,45 % | Minimaler Kursabschlag bei der Sinopharm Group-Aktie (2,20 €) | Der Kurs der dem Anteilsschein der Sinopharm Group kommt kaum von der Stelle. Der jüngste Kurs betrug 2,20 Euro. Jahreschart der Sinopharm Group Ltd.-Aktie, Stand 19.07.2024 Einen geringen Preisabschlag... ► Artikel lesen | |
INDIVA | 0,016 | 0,00 % | XFRA T8RP: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILINDIVA LTD T8RP... ► Artikel lesen | |
CSPC PHARMA | 0,710 | +1,92 % | CSPC PHARMA (01093): CONTINUING CONNECTED TRANSACTIONS - PURSUANT TO RULE 14A.60(1) OF THE LISTING RULES | ||
ORAMED PHARMACEUTICALS | 2,326 | -0,13 % | Oramed Pharmaceuticals Inc.: Oramed Letter to Shareholders | Stock Repurchase Program
Scilex Senior Secured Note
Phase 3 Oral Insulin Trial in US
JV with Chinese Partner, HTIT
NEW YORK, June 26, 2024 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq:... ► Artikel lesen | |
ADASTRA | 0,058 | 0,00 % | Adastra Holdings Ltd.: Adastra Announces Intention to Terminate SEC Reporting Obligations | LANGLEY, BC / ACCESSWIRE / May 1, 2024 / Adastra Holdings Ltd. (CSE:XTRX)(FRA:D2EP) ("Adastra" or the "Company"), a leading cannabis processor and producer of two top Canadian concentrates brands, with... ► Artikel lesen | |
CATALYST PHARMACEUTICALS | 16,100 | -0,59 % | Catalyst Pharmaceuticals, Inc.: Catalyst Pharmaceuticals Enters Into an Exclusive License, Supply and Commercialization Agreement with Kye Pharmaceuticals for AGAMREE in Canada | CORAL GABLES, Fla., July 24, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing... ► Artikel lesen |